Higher low leads to higher high.
Serum (SRMUSD) is in the process of breaking out of a big falling wedge, sealing a strong higher low.
✔️ Next target can be seen around 0.27 which translate into a 150% potential.
✔️ Being more conservative this chart setup can easily do 50%. This is a short-term target.
All the information shared here is for learning and/or entertainment purposes only.
Wishing you tons of success.
The Cryptocurrency market is set to grow. (Ignore the FUD)
Namaste.
Serum (SRMUSD) is in the process of breaking out of a big falling wedge, sealing a strong higher low.
✔️ Next target can be seen around 0.27 which translate into a 150% potential.
✔️ Being more conservative this chart setup can easily do 50%. This is a short-term target.
- The charts are always changing.
- Make sure to build your own plan before trading.
- This is not financial advice.
- I am sharing my views and opinions of the charts.
All the information shared here is for learning and/or entertainment purposes only.
Wishing you tons of success.
The Cryptocurrency market is set to grow. (Ignore the FUD)
Namaste.
🚨 You need PREMIUM trade-numbers to profit from Cryptocurrencies —Best timing & amazing results! 👉 lamatrades.com (Since 2017)
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 You need PREMIUM trade-numbers to profit from Cryptocurrencies —Best timing & amazing results! 👉 lamatrades.com (Since 2017)
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.